Company news
Kailera Therapeutics, Inc. (NASDAQ:KLRA) news
Every Kailera Therapeutics, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Kailera Reports Second Quarter 2026 Financial Results and Provides Business Updates
August 12, 2026
Kailera Therapeutics Appoints Nur Nicholson as Chief Technology Officer
August 11, 2026
Kailera Therapeutics Announces Positive Topline Data from Two Hengrui Pharma Phase 3 Clinical Trials of Oral Small Molecule GLP-1 Recepto...
July 7, 2026
Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026
June 5, 2026
Kailera Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference
May 28, 2026
Kailera Reports First Quarter 2026 Financial Results and Provides Clinical Data Updates
May 26, 2026
Kailera Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
April 20, 2026
Kailera Therapeutics Announces Pricing of Initial Public Offering
April 16, 2026